Radboud University Medical Center

🇳🇱Netherlands

Country: 🇳🇱Netherlands

Ownership: Private

Established: 1951-01-01

Employees: -

Market Cap: -

Website: http://www.radboudumc.nl

Clinical Trials

Improving Bio-availability of the Expensive Oral Oncolytic Drug Abiraterone by Food Intake

Phase 1

Completed

Conditions: Prostate Cancer

Interventions: Drug: abiraterone

First Posted Date: 2016-08-30

Last Posted Date: 2020-12-07

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 14

Registration Number: NCT02883166

Locations: 🇳🇱
Radboud UMC, Nijmegen, Netherlands

Early Treatment Versus Expectative Management of PDA in Preterm Infants

Not Applicable

Completed

Conditions: Patent Ductus Arteriosus

Interventions: Other: Expectative Management
Drug: Ibuprofen
Drug: Indomethacin

First Posted Date: 2016-08-30

Last Posted Date: 2023-07-03

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 273

Registration Number: NCT02884219

Locations: 🇳🇱
Radboudumc Amalia Children's Hospital, Nijmegen, Netherlands
🇧🇪
University Hospital Antwerp, Antwerp, Belgium
🇧🇪
University Hospital Brussels, Brussels, Belgium

and more 10 locations

Effectiveness of Buprenorphine/Naloxone

Conditions: Chronic Pain

Interventions: Other: observational

First Posted Date: 2016-08-29

Last Posted Date: 2018-09-04

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 20

Registration Number: NCT02882412

Locations: 🇳🇱
Radboudumc, Nijmegen, Netherlands

Deferoxamine in Aneurysmal Subarachnoid Hemorrhage Trial

Phase 1

Recruiting

Conditions: Intracranial Aneurysm
Subarachnoid Hemorrhage

Interventions: Other: placebo
Drug: Deferoxamine

First Posted Date: 2016-08-23

Last Posted Date: 2023-04-24

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 40

Registration Number: NCT02875262

Locations: 🇳🇱
Radboudumc, Nijmegen, Gelderland, Netherlands
🇳🇱
University Medical Center Groningen, Groningen, Netherlands

Octreotide in Patients With GI Bleeding Due to Rendu-Osler-Weber

Phase 2

Conditions: Hereditary Hemorrhagic Telangiectasia
Gastrointestinal Hemorrhage
Anemia

Interventions: Drug: Octreotide LAR

First Posted Date: 2016-08-22

Last Posted Date: 2018-04-20

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 15

Registration Number: NCT02874326

Locations: 🇳🇱
Radboudumc, Nijmegen, Gelderland, Netherlands
🇳🇱
St Antonius Hospital, Nieuwegein, Utrecht, Netherlands

Intra-peritoneal Chemotherapy in Ovarian Cancer

Conditions: Ovarian Neoplasms
Effects of Chemotherapy
Neoplasms
Immune Tolerance

First Posted Date: 2016-08-10

Last Posted Date: 2016-08-10

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 15

Registration Number: NCT02861872

Locations: 🇳🇱
Radboudumc, Nijmegen, Netherlands

Deep Versus Moderate Muscle Relaxation During Laparoscopic Donor Nephrectomy in Enhancing Postoperative Recovery

Phase 4

Completed

Conditions: Renal Transplant Donor of Left Kidney
Neuromuscular Block
Renal Transplant Donor of Right Kidney
Surgery

Interventions: Other: No additional Rocuronium
Other: Rocuronium

First Posted Date: 2016-07-20

Last Posted Date: 2019-09-19

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 101

Registration Number: NCT02838134

Locations: 🇳🇱
Radboudumc, Nijmegen, Netherlands
🇳🇱
LUMC, Leiden, Netherlands

Controlled Human Malaria Infection Model for Evaluation of Transmission-Blocking Interventions - Study 1

Phase 1

Completed

Conditions: Malaria

Interventions: Drug: Sulfadoxine-pyrimethamine (low dose)
Drug: Piperaquine (low dose)
Drug: Sulfadoxine-pyrimethamine (high dose)
Drug: Piperaquine (high dose)
Biological: malaria challenge infection, P. falciparum 3D7
Drug: Atovaquone-proguanil

First Posted Date: 2016-07-18

Last Posted Date: 2018-03-23

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 29

Registration Number: NCT02836002

Locations: 🇳🇱
Radboud university medical center, Nijmegen, Gelderland, Netherlands

Compliance With Hand Hygiene in Nursing Homes: Go for a Sustainable Effect (CHANGE)

Not Applicable

Completed

Conditions: Infectious and Communicable Diseases

Interventions: Other: Hand hygiene implementation strategy

First Posted Date: 2016-06-29

Last Posted Date: 2020-10-14

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 20

Registration Number: NCT02817282

Effect of Statins on Trained Immunity

Completed

Conditions: Atherosclerosis

Interventions: Drug: Statin

First Posted Date: 2016-06-29

Last Posted Date: 2023-11-29

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 45

Registration Number: NCT02817230

Locations: 🇳🇱
Erasmus Medical Center, Rotterdam, Netherlands
🇳🇱
Academic Medical Center, Amsterdam, Netherlands
🇳🇱
Radboud University Nijmegen Medical Centre, Nijmegen, Gelderland, Netherlands

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy